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INTRODUCTION 
 
 Although laparoscopic surgery is associated with less pain than 
open procedures, it is definitely not pain- free in the early post-operative 
period.  Post operative pain is variable in severity, nature ,and duration 
and it is one of the main factors that delay discharge of pain  from the  
hospital and this increasing the hospital cost and family discomfort. 
 The etiology of pain after laparoscopic surgery is multifactorial 
including abdominal wall damage, visceral trauma, inflammation and 
peritoneal irritation due to capno-peritoneum. Duration of post-operative 
pain is usually short and last up to 12 hrs (but sometimes even up to 2 
days).The  severity of pain decreases gradually being highest in the 
immediate post-operative period. If  the post-operative pain is adequately 
addressed, it can shorten hospital stay and can speed up recovery. 
 Conventional post-operative pain control methods consist of 
administration of narcotics and  NSAIDS which can control the pain 
effectively, but their side effects such as Respiratory depression, 
drowsiness, sedation, post operative nausea and vomiting, ileus and 
constipation thus it can lead delay hospital discharge. Joint commission 
on Accreditation of Health Organizations has suggested excessive use of 
opioids and NSAID s  in the postop period leads to decrease patient 
  
satisfaction.Therefore ,nowadays surgeons and anaesthesiologists are 
using non-conventional techniques as an adjuvant to minimize the side 
effects of conventional analgesics. 
             Local anesthetic injections are increasingly being used 
intraoperatively for pain control. Applications of local anesthetics after 
operation into the incision is an effective method with few side effects. 
Local anesthetics agents can be utilized in a safe dosage range with 
effective results. The aim of this study is to compare the efficacy and side 
effects of conventional analgesics (opioid, NSAID’s ) with port site 
infiltration of local anesthetic agents for post-operative pain control in 
laparoscopic surgery. 
 
 
 
 
 
 
 
 
 
 
 
  
AIM 
 
 To study the analgesic effect of port site infiltration of bupivacaine 
and compare it with efficacy and side effects of conventional 
analgesics in laparoscopic surgeries. 
 
 To assess the need for rescue analgesics in the early post-operative 
period in both groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
REVIEW OF LITERATURE 
HISTORY OF LAPAROSCOPIC SURGERY 
460-375 BC- Hippocrates in Greece used a speculum to visualize 
the rectum. In 1901,Von ott- inspected the abdominal cavity using 
speculum and candle light and first experimental laparoscopy performed 
by german surgeon Georg kelling in berlin. 
In 1910, H.C. Jacobaeus of Stockholm published a discussion of 
the inspection of the peritoneal, pleural and pericardial cavity. In 1911, 
Bertram M.Bernheim, from Johns Hopkins Hospital introduced first 
laparoscopic surgery and named as “Organoscopy” and the instrument 
used was proctoscope of a half inch diameter and used ordinary light  
for illumination and H.C.Jacobaeus, again coined the term 
“laparothorakoskopie” after using this procedure on the thorax and 
abdomen. In 1918 ,O.Goetze  developed an automatic pneumoperitoneum 
needle for safe introduction to the peritoneal cavity. In 1920, Zollikofer 
of Switzerland discovered the benefit of co2 gas for insufflation, rather 
than filtered atmospheric air or nitrogen. 
In 1929, Kalk, a German physician,  introduced the forward 
oblique (135 degrees) view lens systems. Goetze of Germany first 
developed a needle for insufflations and Heinz kalk, a German 
  
gastroenterologist developed a 135 degree lens system and a dual trocar 
approach.In 1934, John C. Ruddock, an American surgeon described 
laparoscopy as a good diagnostic method than laparotomy.In 1936, 
Boesch of Switzerland was awarded for doing the first laparoscopic tubal 
sterilization. 
In 1938,Janos Veress of Hungary developed a specially designed 
spring loaded needle, called veress needle.In 1939, Richard W.Telinde 
tried to perform an endoscopic procedure by a culdoscopic approach in 
the lithotomy position.In 1953,Professor Hopkins discovered rigid rod 
lens system. The credit of videoscopic surgery goes to this surgeon.In 
1960, Kurt Semm, a German gynaecologist, invented the automatic 
insufflators and Patrick Steptoe adapted the techniques of sterilization by 
two puncture technique.In 1972,H.Courtney Clarke showed a 
laparoscopic suturing technique for hemostasis.                                                                                       
In 1973,Gaylord D. Alexander developed techniques of safe local 
and general anaesthesia  for laparoscopy.In 1977,Dekok performed first 
laparoscopic assisted appendicectomy.   The appendix was exteriorized 
and ligated outside and Kurt Semm demonstrated endoloop suturing 
technique in laparoscopic surgery.   In 1978,  Hasson proposed a blunt 
mini-laparotomy which permits direct visualization  of  trocar entrance 
into the peritoneal cavity. In 1980, Patrick Steptoe  started to perform 
  
laparoscopic procedures.In 1983, Semm, a German gynaecologist, 
performed the first laparoscopic appendicectomy.The first documented 
laparoscopic cholecystectomy was performed by Erich Muhe in Germany 
in 1985.In 1987, Ger reported first laparoscopic inguinal hernia repair 
using prototype stapler and Phillipe Mouret, has  performed the first 
laparoscopic cholecystectomy in Lyons. Laparoscopic Cholecystectomy 
revolutionized the general surgery.In 1988, Harry Reich performed 
laparoscopic lymphadenectomy for treatment of ovarian cancer.  
In 1989, Harry Reich described first laparoscopic hysterectomy 
using bipolar dessication. Later he demonstrated staples and finally 
sutures for laparoscopic hysterectomy and Reddick and Oslen reported 
that CBD injury after laparoscopic cholecystectomy is 5 times more than 
with conventional cholecystectomy. In 1990, Bailey and Zucker in the 
USA popularized laparoscopic anterior highly selective vagotomy. In 
1996, First live telecast of laparoscopic surgery performed remotely via 
the internet. (Robotic Telesurgery). 
 
 
 
 
  
PAIN: 
 The International Association for the study of pain defines pain as 
“ an unpleasant sensory and emotional experience associated with actual 
or potential tissue damage, or described in terms of such damage.” 
CLASSIFICATION OF PAIN: 
 According to pathophysiology- Nociceptive or Neuropathic 
 Etiology- Post-operative or cancer pain 
Pain can be classified into 2 categories: 
1) Acute pain- due to nociception 
2) Chronic pain- due to nociception, neuropathic or mixed 
ACUTE (NOCICEPTIVE ) PAIN:  
 It is caused by an injury to body tissues. Nociceptive pain occurs 
due to the activation of the nociceptive system by noxious stimuli that can 
cause mechanically, chemically or thermally induced damage to tissue 
integrity. 
 The four physiological processes involved  are transduction, 
transmission, modulation, and perception. 
 
  
 This forms of pain include post-traumatic, post-operative, 
obstructive pain and pain associated with acute medical illness such as 
myocardial infarction, pancreatitis ,and renal calculi. Most forms of acute 
pain are self- limited or resolve with treatment in a few days or weeks. If 
it fails to resolve due to inadequate treatment or abnormal healing, the 
acute pain becomes chronic pain. 
 The two types of acute (nociceptive) pain are  
a) Somatic pain 
b) Visceral pain 
SOMATIC PAIN: 
 This is further classified into 
a) Superficial pain 
b) Deep pain 
 
 Superficial somatic pain is due to nociceptive input from skin, 
subcutaneous tissue, and mucous membrane. This pain is well 
localized and sharp, pricking, throbbing and burning pain. 
 Deep somatic pain arises from muscles, tendons, joints or bones. This 
pain has dull aching quality and not well localized.  
 
  
VISCERAL PAIN: 
This form of acute pain is due to disease or abnormal function of 
an internal organ or its coverings (parietal pleura, pericardium or 
peritoneum). 
The four types of visceral pain include: 
i. True localized visceral pain 
ii. Localized parietal pain 
iii. Referred visceral pain 
iv. Referred parietal pain 
 True visceral pain is characterized by dull and diffuse in nature and 
usually in the midline. This is frequently associated with abnormal 
sympathetic and parasympathetic activity such as abnormal blood 
pressure, sweating, nausea, and vomiting with changes in heart rate. 
 Parietal pain is usually sharp and stabbing sensation which either 
localized to the diseased area or referred to a distant area. 
CHRONIC PAIN: 
 Chronic pain
2
 is defined as pain that persists after the usual course 
of acute disease for a time period varying from one to six months. It may 
be due to nociception, neuropathic or mixed. The important 
  
distinguishing feature in chronic pain is psychological and environmental 
factors which play a major role. 
 The most common form of chronic pain includes musculoskeletal 
disorders, chronic visceral disorders, lesion of peripheral nerves and 
nerve roots (diabetic neuropathy, phantom limb pain, post -herpetic 
neuralgia), lesion of central nervous system (stroke, multiple sclerosis 
,and spinal cord injury) and cancer pain. 
 The pain due to musculoskeletal disorders is primarily due to 
nociception, whereas pain associated with peripheral or central neural 
disorder is primarily due to neuropathic. The pain associated with cancer 
or chronic back pain is mixed one. 
ANATOMY AND PHYSIOLOGY OF NOCICEPTION: 
PAIN PATHWAY: 
Pain is conducted along three neuron pathway that transmits 
noxious stimuli from periphery to cerebral cortex. Primary afferent 
neurons are located in dorsal root ganglion at each spinal cord level. 
In the dorsal horn, primary afferent neurons synapses with second-
order neuron whose axons cross the midline and reach the controlateral 
spinothalamic tract to reach the thalamus.  Second order neurons in the 
  
thalamus, synapse with third -order neurons which project axons to the 
post central gyrus of the cerebral cortex. 
FIRST ORDER NEURON:  
The first order neuron sends proximal end of axons to the spinal 
cord via dorsal (sensory) spinal root at each cervical, thoracic, lumbar and 
sacral level.  
In a dorsal horn, in addition to synapse with second- order neuron, 
the axons of first -order neuron also synapse with interneurons and 
sympathetic neurons. 
SECOND ORDER NEURON: 
The afferent fibres enter the spinal cord according to the size. 
Large myelinated fibres become medial and small unmyelinated fibres 
becomes lateral. The pain fibres may ascend or descend three spinal cord 
segments in lissauer’s tract before synapse with second order neurons in 
the grey matter of ipsilateral dorsal horn. Spinal cord grey matter was 
divided into ten laminae. The second order neurons are either nociceptive 
specific or wide dynamic range (WDR) neurons which receive all 
noxious afferent inputs. 
 
  
THIRD ORDER NEURON:  
The third order neurons are located in the thalamus and send fibres 
to somatosensory areas 1 & 2 in the post central gyrus of parietal cortex. 
NOCICEPTORS: Most nociceptors are free nerve endings that sends 
heat, mechanical and chemical tissue damage.  
There are several types of  Nociceptors. 
 Mechano-Nociceptors- generally responds to pinch and pin prick , 
mediate fast/first pain, via Aδ (small, myelinated ) afferent fibres. 
 Polymodal Nociceptors- most prevalent and respond to excessive 
pressure and extremes of temperature (>42
0
C and <18
0
C ) and 
alogens, mediate slow/second pain, via C (small, Unmyelinated ) 
afferent fibres. 
 Silent Nociceptors- responds only to tissue damage or in the presence 
of inflammation. 
Nociceptors also differ in their speed of conduction and in their 
capacity to be sensitized during inflammation, injury, and disease. The A-
delta fiber and the C-fiber nociceptors are the 2 main classes of 
nociceptors. C-fibres are the most common; about 70% of all nociceptors 
are of the C-fibre type. Their axons are unmyelinated and their cell bodies 
are small. When activated, C-fibres conduct action potentials slowly, 
  
resulting in prolonged burning pain. A-delta fibres have thinly myelinated 
axons with medium to large diameter cell bodies. When activated, they 
conduct impulses at a fast rate and produce sharp, pricking pain. 
The nociceptive pain pathway consists of 4 processes: 
transduction, conduction, transmission and perception. Nociception 
begins with the activation of the specific receptors or ion channels in the 
peripheral terminals of nociceptors by noxious stimuli. The activated 
receptors convert the noxious stimuli into electrical current, a process 
called transduction. The current generated at the peripheral terminals of 
sensory fibres depolarizes the nociceptor membranes generating action 
potentials. The latter is conducted along the nociceptor axons to their cell 
bodies, located in the dorsal root ganglion (DRG) in the spinal cord, and 
then to their central terminals located in the dorsal horn. Here the action 
potentials initiate neurotransmitter release from nociceptor central 
terminals which relay the signal across synapses (transmission)  to the 
dorsal horn neurons. The signal is then relayed via ascending nociceptive 
pathways to higher centers in the brain where it is perceived as pain 
(perception). 
 
 
  
GATE CONTROL THEORY: 
 This was proposed in an attempt to overcome the limitations of a 
specific and direct neural pathway serving pain and nociception. 
The basic concept is that signals elicited in afferent neurons by 
noxious stimuli can be blocked or filtered by a synaptic ‘gate’ in the 
dorsal horn of the spinal cord. The story is complex and there are many 
controversial features. However, the principle does seems to work in 
practice, even if the precise mechanisms are unsettled. 
The ‘gate’ is believed to be located in the substantia gelatinosa 
(SG) of the dorsal horn. Neurons of the SG make connections with the 
terminals of primary afferent fibres and also the dendrites of dorsal horn 
cells. Through either pre-synaptic or postsynaptic inhibition, the 
substantia gelatinosa neurons appear to be able to block (or reduce) 
activation of second- order neurons by nociceptive inputs; these ‘gating’ 
effects of the SG neurons can be activated by  inputs in large diameter(A) 
afferents innervating the injured area. (This provides the basis for pain 
relief by selective activation of large diameter afferents, as in 
transcutaneous electrical nerve stimulation-TENS) 
Activation of neurons in certain brainstem regions, which send 
axons to the spinal cord. 
 
  
CNS PATHWAYS 
 Nociceptive afferents synapse with two main groups of neurons in 
the dorsal horn: 
• Lamina I: nociceptive neurons (Aδ, C) 
• Lamina V: somatic and visceral nociception and non-
nociception. 
There are several projection pathways from the spinal cord to the 
brain: 
(a) A ‘specific’ pathway, probably the spinothalamic tracts, crosses the 
midline and projects to the thalamus and then to somatosensory 
cortex. The lateral spinothalamic tract (neospinothalamic) projects 
mainly to ventroposterolateral nucleus of thalamus which carries 
discriminative aspects of pain. Medial spinothalamic tract 
(paleospinothalamic) projects to the medial thalamus, responds for 
mediating autonomic and unpleasant perceptions of pain. 
(b)  A ‘non-specific’ pathway, includes the spinoreticular tracts, 
spinomesencephalic tract which relays fibres to controlateral thalamus 
and projects to many areas of forebrain which carries affective aspects 
of pain. 
 
 
  
VISCERAL PAIN PATHWAY 
 
  
 
 
  
POST OPERATIVE  PAIN : 
 Pain is defined as ‘an unpleasant sensory and emotional experience 
associated with actual or potential damage’. 
 It is a complex process influenced by both physiological and 
psychological factors. 
EFFECTS OF POSTOPERATIVE PAIN: 
Postoperative pain can affect all organ systems and includes 
 Respiratory-atelectasis, reduced cough, sputum retention and 
hypoxaemia 
 Cardiovascular- increased myocardial oxygen consumption and 
ischemia 
 Gastrointestinal- decreased gastric emptying, reduced gut motility, and 
constipation 
 Genitourinary- urinary retention 
 Neuroendocrine- hyperglycemia, protein catabolism and sodium 
retention 
 Musculoskeletal- reduced mobility and increased risk of  DVT 
 Psychological- anxiety and fatigue 
The postoperative pain can be partially or completely controlled 
by one of the following methods: 
  
i. Pharmacological method and adjuvants 
ii. Local infiltration and field block 
iii. Regional analgesia with local anaesthetics. 
iv. Regional analgesia with epidural or intrathecal opioids. 
v. Regional analgesia with combined LA and opioids. 
vi. Electrical analgesia. 
PHARMACOLOGICAL METHODS OF PAIN RELIEF: 
NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS): 
 Inhibits the enzyme cyclo-oxygenase. 
 Reduces prostaglandin, prostacyclin and thromboxane synthesis. 
 NSAID’s acts as antipyretics, analgesics ,and anti-inflammatory 
agents. 
 Prostaglandins play a protective role in the stomach and non-
selective COX  inhibitors can cause GI toxicity (peptic ulcer) on 
long time use. 
 CLASSIFICATION:  
1) Non-selective COX inhibitors (inhibits both cox 1 and cox 2) 
2) Selective COX-2 inhibitors. 
 
 
  
1) NON-SELECTIVE COX INHIBITORS: 
 Commonly used are Paracetamol and salicylates 
 Other drugs are Indomethacin, mefenamic acid, ketorolac, 
piroxicam 
 Aspirin is the only irreversible inhibitor of COX enzyme 
 Other salicylates are reversible cox inhibitors. 
 Side effects include: 
o Gastric irritation and peptic ulceration 
o Precipitation of bronchospasm in asthmatics 
o Impairment of renal function 
o Platelet dysfunction and bleeding 
o Dose- dependent effects on acid- base balance. 
PARACETAMOL: 
o It is a weak anti-inflammatory agent 
o Modulates prostaglandin production in the central nervous system 
o Can be administered orally or rectally or intramuscularly 
o Overdose results in Hepatotoxicity 
o N-Acetyl cysteine is used as an antidote for paracetamol poisoning 
KETOROLAC: 
o Derivative of Dihydropyrrolizine carboxylic acid  
o Structure related to indomethacin 
  
o It is a NSAID- belongs to non- selective cox inhibitor, used for short 
term management for moderate to severe pain. 
o Available as oral/intramuscular/intravenous/nasal spray/eyedrops. 
o The ophthalmic preparation was approved by FDA in 1992  and 
intranasal formulation was approved by FDA in 2010. 
o Its bioavailability is 100% on all routes, metabolized in the liver. Its 
half- life is 3-9hours. Excretion is mainly through kidney (90%) and 
biliary (10%) 
o Dose is 30mg im/iv every 6hrs as needed, max dose is 120mg/day. 
Oral dose-20mg followed by 10 mg every 4-6hrs as needed, max-
40mg/day. 
o Adverse effects- though uncommon, drowsiness, paraesthesia, 
prolonged BT, injection, site pain, dry mouth, abnormal taste.  Severe 
complication- stroke, MI, GI bleeding, steven Johnson syndrome, 
anaphylaxis. 
2) SELECTIVE COX INHIBITORS: 
 They have the advantage of very little GI toxicitiy. There is a 
chance of thrombosis (MI and stroke)  on prolonged use. 
 
 
 
 
  
OPIATES: 
o These are substances obtained from a crude extract of papaver 
somniferum (poppy plant). Morphine is a prototype opioid, acts by 
agonist on µ, kappa and delta receptors. 
o Actions mediated by opioid
2
 receptors: 
• µ-sedation, analgesia, constipation, respiratory depression, 
truncal rigidity, euphoria, miosis 
• Kappa receptors- Dysphoria, constipation, and analgesia 
• Delta receptors- spinal analgesia, modulation of hormone and 
neurotransmitter release. 
o Route of administration-oral, rectal,  iv, im, intrathecal, epidural. 
Fentanyl is available as a transdermal patch and buccal transmucosal 
route. Butorphanol is the only opioid available in the nasal 
formulation. 
TRAMADOL: 
 It is a weak µ agonist receptor, serotonin and nor-epinephrine 
reuptake inhibitor and serotonin 5HT2c receptor antagonist, M1 and M3 
muscarinic acetylcholine receptor antagonist. It acts on opioid 
receptors through its major active metabolite is desmetramadol. 
 
  
 Bioavailability is 70-75% (oral), 77% (rectal), 100% (im).  
 Protein binding is 20%.  
 Metabolized mainly by the liver, by demethylation and 
glucuronidation.  
 Its half -life is 6+ 1.3 hr. Excretion is through kidney (95%) 
 The dose is 50-100 mg orally 4-6 hrs the maximum is 400 mg/day. 
 It is used primarily for moderate to severe pain for both acute and 
chronic. Its side effects most commonly include nausea, dizziness, dry 
mouth, vomiting, indigestion, headache, constipation. On long -term 
use it leads to physical dependence and withdrawal syndrome, 
convulsion at the high dose. 
LOCAL ANAESTHETIC AGENTS AND TECHNIQUES: 
 Local anaesthesia produces loss of sensation to pain in the specific 
area of the body without the loss of consciousness. 
  It blocks transmission of impulses along the nerves usual for pain 
control. 
 Broadly classified into Amide and Ester groups. 
 Amide groups includes-  
o Lidocaine,  
o Bupivacaine,  
o Mepivacaine,  
  
o Etidocaine,  
o Prilocaine. 
 Ester groups include- 
o Cocaine,  
o Procaine,  
o Chlorprocaine,  
o tetracaine 
 Local anesthetics block the generation and the conduction of nerve 
impulses by reducing the rate of rising of the action potential.  
 The progression of anaesthesia is related to the diameter, myelination, 
and conduction speed of affected nerve fibers.  
 The order of loss of nerve function is as follows:  
(1) pain,  
(2) temperature, 
 (3) touch,  
(4) proprioception, and  
(5) skeletal muscle tone. 
 Systemic absorption of local anesthetics produces effects on the 
cardiovascular and central nervous system (CNS).  
 
  
 Properties of ideal Local anaesthetic agents- Reversible action, non-
irritant, no allergic and systemic reactions, potent, rapid onset of 
action and sufficient duration of action and should not be too 
expensive. 
 Can be used by : 
o Wound infiltration 
o Nerve or nerve plexus blockade 
o Epidural infiltration 
o Intrathecal (spinal) administration 
o Intra peritoneal instillation. 
 Lignocaine has rapid onset but short duration of action 
 Bupivacaine has more prolonged onset and duration of action. 
 
BUPIVACAINE: 
CHEMICAL STRUCTURE: 
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 Bupivacaine HCL is chemically designated as  
2-piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, 
monohydrochloride, monohydrate. 
Bupivacaine belongs to the amide group of local anaesthetic
6 
agents and chemically related to lidocaine. It is available as 0.25%, 0.5%, 
0.75%. 
    
 
    
 
  
PHARMACOKINETICS:  
The onset of action is rapid and anesthesia is long lasting.  The pKa 
of bupivacaine is 8.1. 
Bupivacaine possesses a greater degree of lipid solubility and 
protein binding. 
It is metabolized primarily in the liver via conjugation with 
glucuronic acid. Hence patients with the severe hepatic disease, may be 
more susceptible to the toxicities. The systemic absorption of local 
anaesthetics depends on site of injection (IV>tracheal>intercostals> 
caudal>epidural>brachial plexus> subcutaneous), presence of 
vasoconstrictors (epinephrine causes vasoconstriction at the site of 
administration and hence enhances the quality of anaesthesia, prolongs 
the duration of action and limits the toxicity).  
The half-life of Bupivacaine Hydrochloride in adults is 2.7 hours 
and in neonates 8.1 hours. The kidney is the main excretory organ for 
most local anesthetics and their metabolites. Only 6% of bupivacaine is 
excreted unchanged in the urine. 
DOSAGE: 
 Maximum dosage: 3mg/kg 
 Maximum in 24 hours is 400 mg 
 
  
ADVERSE REACTIONS: 
CENTRAL NERVOUS SYSTEM REACTIONS:   
Early symptoms are circumoral numbness, tongue paraesthesia, 
dizziness, tinnitus, blurred vision, restlessness which often precedes CNS 
depression and tonic-clonic seizure followed by respiratory depression. 
Thiopentone 1-2mg/kg  terminates seizure attack. 
CARDIOVASCULAR SYSTEM REACTIONS:   
The unintentional intravascular injection may lead to severe 
cardiotoxic reactions like hypotension, atrioventricular heart block, 
idioventricular rhythms and life- threatening arrhythmias like ventricular 
tachycardia and fibrillations. Young children are more susceptible for 
toxicities. Pregnancy, hypoxia ,and acidosis are predisposing risk factors 
for toxicities. 
Isoprotrenol effectively reverses some of the electrophysiological 
abnormalities of bupivacaine toxicities. 
CONTRAINDICATIONS: 
 It is contraindicated in the obstetrical paracervical block since it 
predisposes to fetal bradycardia and death. 
 It is also contraindicated in patients with a known hypersensitivity 
to any local anesthetic agents. 
 
  
CLINICALLY SIGNIFICANT DRUG INTERACTIONS: 
 The administration of  bupivacaine containing epinephrine to 
patients receiving monoamine oxidase inhibitors or tricyclic 
antidepressants may produce severe, prolonged hypertension.  
ADRENALINE: 
 Adrenaline can delay absorption and prolong duration of action 
 Should not be used at sites of end-arteries (e.g. ear, fingers, penis) 
 Act by reducing transmission along nerve fibres 
 Work by blocking sodium channels in the nerve fibres 
 Block pain-fibres first but can also result in  
o Neuromuscular blockade 
o Hypotension due to sympathetic blockade 
ASSESSMENT OF PAIN: 
 Pain is a subjective experience 
 Observer assessment of patient behavior is unreliable 
 Pain should be assessed and recorded by: 
o Visual analogue scales 
o Verbal numerical reporting scale 
o Categorical rating scale 
 
 
  
VERBAL PAIN SCALES 
 Verbal pain scales is used to describe the pain. Words like no pain, 
mild pain, moderate pain and severe pain are used to describe pain levels. 
A score from 0 to 3 is designated to each of those word pairs and used to 
measure pain levels. 
 
NUMERICAL RATING SCALES: 
 A numerical scale with the range of 0 to 10 is an another type of 
pain scale. The words like “no pain” appears by the ‘0’ and “worst pain 
possible” is found by the “10” and the patient is asked to choose a 
number from 0 to 10 that reflects the level of pain. 
 
VISUAL ANALOGUE SCALE (VAS): 
 VAS use a vertical or horizontal line with words that convey “no 
pain” at one end and “worst pain” at the opposite end.The patient is asked 
to place a mark along the line that best indicates the level of pain. When 
using VAS clinician should explain the patient about this scale clearly. 
 
  
 
 
• 0-no pain 
• 1-3- mild pain 
• 4-7- moderate pain 
• 8-10- intense pain 
 
WONG-BAKER FACES PAIN RATING SCALE: 
  In the wong-baker face pain rating scale, six faces are used which 
are numbered from 0 to 5. 
 
  
 
 
Face 0 is a happy face (no hurt) 
Face 1 is still smiling (hurts a little bit) 
Face 2 is not smiling or frowning (hurts a little more) 
Face 3 is starting to frown (hurts even more) 
Face 4 is definitely frowning (hurts a whole lot) 
Face 5 is crying although patient don’t have to cry to choose this face 
(hurts the worst) 
 This pain scale is particularly used in children. 
 
FLACC SCALE: 
 This acronym FLACC means face, legs, activity, crying, and 
consolability. It is an observer -rated pain scale. It is designed for children 
between the ages of 2 and 7. It is also used in adults who are unable to 
communicate their pain. FLACC  provides a pain assessment scale 
between 0 and 10.  
  
FLACC SCALE  
(FACE,LEGS,CRY,ACTIVITY,CONSOLABILITY SCALE) 
SCORE 
FACE 
0- No particular expression or smile 
1- Occasional grimace or frown, withdrawn, disinterested 
2- Frequent to constant quivering chin, clenched jaw 
 
LEGS 
0- Normal position or relaxed 
1- Uneasy, restless, tense 
2- Kicking or legs drawn up 
 
ACTIVITY 
0- Lying quietly, normal position  moves easily 
1- Squirming, shifting back and forth, tense 
2- Arched, rigid or jerking 
 
CRY 
0- No cry (awake or asleep) 
1- Moans or whimpers: occasional complaints 
2- Crying steadily, screams or sobs, frequent complaints 
 
CONSOLABILITY 
0- Content, relaxed 
1- Reassured by occasional touching, hugging or being 
talked to  distractible 
2- Difficult to console or comfort 
 
TOTAL SCORE (0-10)  
 
 
 
  
MCGILL PAIN QUESTIONNAIRE (MPQ) : 
 
 It contains check list of words describing pain in 3 major 
dimensions. 1. Sensory-discriminative, 2. Motivational- affective, 3. 
Cognitive-Evaluative. It contains 20 set of words grouped into 4 groups.  
1. 10- Sensory 
2. 5- affective 
3. 1-Evaluative 
 
According to his or her pain, the patient will select set of words 
that apply. This MPQ can be completed in 5-15 mins. 
 
CRIES SCALE: 
 It assesses crying, oxygenation, vital signs, sleeplessness, and 
facial expression in infants < 6 months. 
 
 
 
 
 
  
LAPAROSCOPY: 
 Minimal invasive surgery and laparoscopic surgery is currently 
practiced worldwide. So it is necessary to have knowledge of basic 
procedures, indications and its limitations. 
INSTRUMENTATIONS:  
It includes optics, abdominal access instruments and laparoscopic 
instruments. 
 
I. OPTICS- it includes  
1. Rod lens system- diameter of the lens is 1-5.5mm, 
2. Fibre optic cables- contains incoherent bundles of fibres with 
random arrangement on either side, 
3. Light source- contains tungsten bulb, xenon bulb, halogen bulb and 
a halide bulb. Xenon bulb will produce white light and less heat, halogen 
bulb will produce yellow light and more heat.  
II. ABDOMINAL ACCESS INSTRUMENTS-  
 for open’s technique- Hasson cannula and for closed technique- 
veress needle. 
VERESS NEEDLE- spring- loaded obturator needle, it is used for 
creating pneumoperitoneum in closed technique of laparoscopy. It comes 
  
in 2 sizes-120 cm and 150 cm. 150 cm is used in obese patients. Its side 
effects are injury to vessel and bowel and preperitoneal placement.  
 
 
 
  INSUFFLATORS- is automatic, pressure regulated and high 
flow, usually flow rate of 8-10 Litre/min. It also monitors intraabdominal 
pressure which usually set at a range of 12-15 mm Hg. There will be an 
alarm sound when pressure limit is exceeded. Two flow rate settings are 
available. Low-pressure insufflation at 1 Litre/min and rapid insufflation 
at 6-10 Litres/min. The approximate length of sterile insufflator tubing 
(3m) is required. 
 
 
 
  
Electronic insufflators has a digital display which monitors – 
1.The pressure at the tip of veress needle or trocar sheath during 
insufflation,  
2. Flow rate in litres/min,  
3. Intraabdominal pressure,  
4. The volume of gas used at any given time during the procedure.  
 
III. LAPAROSCOPES
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- may be rigid or flexible. Size ranges from 3-
10 mm up to 18 mm. angles include-0
0
/end on/ front wing. Commonly 
used angles are 30
0
 and 45
0 
 to look around corners and especially 
used in advanced lap procedures. 
VIDEO IMAGING SYSTEM  
Basic component required for video laparoscopy includes  
1. Light source,  
2. Fibre-optic cable,  
3. Telescope,  
4. Video camera system,  
5. Video monitor,  
6. Video recorder. 
 
  
 Either a Xenon light source or 250 Watt halogen lamp is required. 
A fibre optic light which is 5 mm thick and 225 cm long is desirable. 
Thick cables carry more light and long cables are more convenient so that 
it will not be stretched and damaged. Cables should be handled with 
utmost care and should not be bent sharply anywhere along its length 
during its use. Most commonly used telescopes are rigid instruments that 
use Hopkin’s rod lens system of optics. Rigid laparoscopes come in sizes 
ranging from 3mm to 10 mm in diameter and variety of viewing lenses. 
The 0 degree or end/forward viewing laparoscopy is easy to use with the 
brightest image. Angled scopes 30 degree provides easy accessibility to 
look around corners. Recently flexible laparoscopes have been developed 
that provides even greater flexibility in viewing angle. 
 Video camera system is composed of ‘chip camera’, controller, a 
high -resolution video monitor and a recorder. Video cameras are 
available in 1.25 and 1.67 cms based on either single or triple chip design. 
Automatic white balance is essential. 
 
PNEUMOPERITONEUM:  
It is required to create the working space. Gases used are air, 02, 
CO2, N20, He, Ne, and Ar(recently used). Commonly used is C02.  
 
 
  
Advantages of C02 are-  
1. do not produce combustion or explosion,  
2. it is rapidly absorbed,  
3. it is rapidly soluble and hence less chance of air embolism. 
Although laparoscopic surgeries produce an excellent outcome, 
pneumoperitoneum will produce pathophysiological changes. Most 
challenged system during laparoscopy is the cardiovascular system. The 
two main factors are hypercarbia and increased intraabdominal pressure.  
 
HYPERCARBIA AND ACIDOSIS- CO2 is highly soluble and 
very rapidly absorbed from the peritoneal cavity. The direct effect of co2
19 
and acidosis can lead to decreased cardiac contractility and sensitize the 
myocardium to arrhythmogenic effects of catecholamines and 
vasodilatation. Hypercarbia can lead to sympathetic stimulation resulting 
in tachycardia and vasoconstriction. Hypercarbia can only be avoided by 
compensatory hyperventilation.  
INCREASED INTRAABDOMINAL PRESSURE-it leads to 
mechanical impairment of venous return and decreasing the cardiac 
preload. 
 
  
 
CARDIOVASCULAR COMPLICATIONS:   
Cardiac changes commonly occur during laparoscopic surgeries 
which can be well managed. Complications are hypertension, 
hypotension, arrhythmias and cardiac arrest. Hypertensive episodes are 
more dangerous because of risk of  haemorrhagic strokes and pulmonary 
edema. Hypotension is rare occurring in 13% of laparoscopic surgeries. It 
occurs mainly when intraabdominal pressures exceed 20mm Hg due to 
decreased venous return. High intra thoracic pressure during positive 
pressure ventilation further impairs the venous return.  
The incidence of arrhythmia is as high as 14-27% of laparoscopes 
due to myocardial irritability induced directly by co2. Most arrhythmias 
are transient and respond to reduction of intraabdominal pressure. Cardiac 
arrest is due to the profound vasovagal response to rapid peritoneal 
distension and gas embolism. 
PULMONARY COMPLICATIONS
23-26
: 
 It includes hypoxemia, barotrauma, pulmonary edema and 
atelectasis. Gas embolism, subcutaneous emphysema, pneumothorax, 
pneumomediastinum
30
 ,and pneumopericardium or distinct complications 
of laparoscopic surgeries. 
  
 
GAS EMBOLISM:  
The risk of symptomatic gas emboli
27-29 
depends on types of gas 
and its solubility. Helium, argon, nitrogen has lower solubility compare to 
co2 and hence increased risk of embolization. Clinically gas embolism 
presents as profound hypotension, dyspnoea, cyanosis and arrhythmia, 
and asystole. If gas embolism is suspected, series of measures has to be 
performed immediately which includes- 
1.Release the pneumoperitoneum, 
2. Place the patient in left lateral decubitus with head down position, 
3. Hyperventilation and administration of 100% oxygen and helps in 
rapid elimination of co2. 
4. central venous catheter should be placed immediately to aspirate the 
gas. 
5. aggressive cardiopulmonary resuscitation. 
RENAL COMPLICATIONS:  
Most common is oliguria due to direct mechanical compression of 
renal arteries, increased ADH and reduced cardiac output. An easier 
  
method of maintaining renal perfusion is sufficient intravascular loading 
before and during pneumoperitoneum. 
STEPS  IN LAPAROSCOPY: 
1. PREPARATION OF ABDOMEN- the entire abdominal wall 
should be prepared from midchest to mid- thigh and lateral also 
because at times laparoscopic surgeries may become difficult and 
may require additional trocars away from the operating site. 
 
2. INSERTION OF VERESS NEEDLE-: 
 
 
 
The safest access is the umbilical area because the anterior 
abdominal wall is thinnest in this area.  
  
a. The anterior abdominal wall is elevated from the intra 
abdominal contents by grabbing the abdominal wall in one 
hand.  
b. 1 mm incision is made at the umbilicus 
c. Spring function of veress needle is checked, then the needle 
is slowly inserted into the incision angling towards the pelvis 
and advanced into the peritoneal cavity. 
d. The veress needle is then connected to the insufflation tube 
and insufflation started at a low flow. And intraabdominal 
pressure monitored which should not exceed 8 mm Hg. If it 
is high, it is not in a right position. If veress needle is in the 
right position, proceed with trocar incision. 
e. Then the trocar is inserted and its number depends upon the 
surgery.  
 
 
 
 
  
 
MERITS OF MINIMAL ACCESS SURGERY: 
The open conventional technique has certain intrinsic 
disadvantages, which influence the postoperative period and delays 
patient recovery
18
. 
The advantages of minimal access surgery are 
i. The instruments used for laparoscopic surgery are small and 
will cause less tissue trauma
 7-8 
to the patient and thus patients 
postop recovery is accelerated. 
 
a) 10mm trocar 
and cannula 
 
b) 5mm trocar 
and cannula 
  
ii. Post-operative pain is largely due to incision wound. The most 
common complications associated with open surgery are a 
pulmonary collapse, infections, and DVT. The opioid analgesia 
used for postop pain has its own adverse effects. All these can 
be avoided in laparoscopic surgery. 
iii. The gross manipulation during surgery in open method will lead 
to adhesion formation. These adhesions are minimal in minimal 
access surgery. 
iv. Reduced overall costs for the procedure by shortening of 
hospital stay
14
 in minimal access surgery. 
v. Reduced contact with patients blood during the procedure and 
hence there is diminished risk of transmission of viral diseases. 
LIMITATIONS OF MINIMAL ACCESS SURGERY: 
i. There is a lack of direct handling of tissue with loss of tactile 
sensation, which is important in identifying pathology. 
ii. Control of bleeding is difficult to achieve endoscopically. 
iii. It requires more technical knowledge. 
iv. In difficult endoscopic operation, iatrogenic intraoperative injuries 
can occur. 
v. Organ extraction is difficult in sometimes. 
 
  
COMPLICATIONS OF MINIMAL ACCESS SURGERY: 
 The principle types of complications associated with laparoscopic 
surgery are 
i. Insertion related -   major vascular injury 
Bladder injury 
Gastrointestinal injury 
CO2 embolus 
Abdominal wall injuries 
Haemorrhage. 
ii. Post insertion related - Gastrointestinal perforation 
Bleeding from solid organs 
Abdominal wall hernias 
iii. Pneumoperitoneum related- CO2 embolism 
    Dearrangement of liver functions 
    Hypercarbia related complications
       
 The incidence of trocar related complications ranges from 1:500 to 
1:2000. The use of high -frequency electrocautery has specific morbidity 
such as diathermy burns, bowel perforations, collateral damage to bile 
ducts. The risk of bladder injury can be minimized by decompression 
with foley’s catheterization. An incisional hernia that develops at the 
  
laparoscopic port site has a high chance of incarceration. Closure of 
fascia in all ports 10mm or  more than in diameter should be done to 
avoid this complication. 
 
GENERAL GUIDELINES IN LAPAROSCOPY: 
 The best operating intra-abdominal pressures are between 10 to 
15 mm Hg. 
  Patients position  (operating table to Trendelenberg or Reverse 
Trendelenberg, right or left tilt ) can be given according to the 
area for the surgery is needed.  
 High intra abdominal pressure will cause hemodynamic and 
pulmonary compromise. So that should be avoided. 
 Laparoscopic surgeries has its own contraindications in patients 
with uncorrectable coagulopathy, frozen abdomen, hemorrhagic 
shock , severe cardiac dysfunction, intestinal obstruction with 
massive abdominal distension. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG.1 PORT SITES IN  
LAPAROSCOPIC 
APPENDICECTOMY 
FIG.2 PORT SITES IN  
LAPAROSCOPIC 
CHOLECYSTECTOMY 
  
MATERIALS AND METHODS: 
 
STUDY DESIGN:  
Prospective, Randomized, Controlled study. 
SAMPLE SIZE AND RANDOMIZATION:  
This study includes 100 patients, ASA I and II grade, scheduled for 
laparoscopic surgery in the department of general surgery, Coimbatore 
medical college hospital, Coimbatore between August 2015 to September 
2016. The study was approved by ethical committee of the hospital and 
informed written consent obtained from all the patients. 
 Patients were randomly divided into 2 groups, containing 50 
patients each. Randomization was done consecutively ie first candidate 
was allocated to Bupivacaine while the second patient was allocated to 
conventional analgesia. 
 GROUP-A : Received 20 ml of 0.25% was infiltrated through the 
abdominal wall around each port site. (5 ml to each port site) (6ml for 
10mm port and 4ml for 5mm port) 
 GROUP-B: Received 100 mg of tramadol-slow iv at the end of the 
procedure. 
 
  
INCLUSION CRITERIA:  
 Uncomplicated symptomatic cholelithiasis
16
 
 Sub-acute appendicitis 
 Incision hernia repair 
 Inguinal hernia repair 
 Age >12 years < 65 years 
 ASA I, II 
EXCLUSION CRITERIA: 
 ASA III and more 
 Allergy to NSAID’S or local anaesthetics 
 Age <12 years and >65 years 
 Pregnancy and lactation 
 Previous extensive abdominal surgery 
 Conversion to open surgery 
 Inability to understand and use of VAS scale 
ANAESTHESIA: 
 A conventional balanced general anaesthesia was administered to 
all the patients with a calculated dose of Inj.Glycopyrrolate, 
Inj.Midazolam, Inj. Propafol, Inj.Atracurium. Anaesthesia was 
  
maintained with oxygen, N20, Isoflurane, and Inj.Atracurium as and 
when needed. 
 All patients received Ranitidine and ondansetron as antiemetics. 
Intra-operatively patients were monitored including Heart rate, 
Respiratory rate, continuous ECG, NIBP, SpO2, and ETCO2. 
SURGICAL TECHNIQUE: 
All surgeries were performed in the department of general surgery, 
CMCH. 3 ports were used for laparoscopic appendicectomy and  4 ports 
were used for laparoscopic cholecystectomy
11
. 
Access to the peritoneal cavity was established using veress needle. 
For easy accessibility,the position of the table was changed. 
(Trendelenburg or reverse Trendelenburg) according to the nature of the 
surgery. 
An insufflation pressure of 12-15mm Hg was routinely used 
throughout the operation. 
POST-OPERATIVE PAIN ASSESSMENT: 
 All the data’s were entered into a proforma for all patients which 
include sex, the weight of the patient, duration of surgery, postoperative 
  
pain assessed by VAS (Visual Analogue scale), Requirement of rescue 
analgesia and possible side effects of Bupivacaine and Tramadol. 
 The primary analysis was postoperative pain intensity
12,13 
was 
assessed using VAS score at 1,4,8 and 12 hrs after surgery. 
VAS score of 0-10 was explained to the patient pre-operatively. 
  0-No pain 
 1-3- Mild pain 
 4-7- Moderate pain 
 8-10- Intense pain 
The intensity of pain was assessed using 10 ports. VAS score of 
1,4,8 and 12
th
 hour postoperatively. 
The secondary analysis includes rescue analgesia requirement and 
side effects of opioids (Tramadol). 
Injection ketorolac 30mg Intravenous was given as rescue 
analgesia when demanded by the patient within 1
st
 12 hours. 
 
 
 
  
 
 The software used was Spss version 21.the data collected was 
entered in Microsoft Excel.The categorical data was expressed as a 
percentage. The continues data was expressed in mean ± standard 
deviation. Unpaired  t- test was used between two groups for comparison. 
Then ‘P’ value of < 0.05  was taken as statistically significant between 
the 2 groups. Kruskal Wallis test used to compare categorical parameters 
in more than 2 groups.  
 
 
 
 
 
 
 
 
 
  
OBSERVATION AND RESULTS 
The study was conducted between August 2015 to September 
2016.  Patients were admitted in the department of general surgery for the 
management of uncomplicated cholelithiasis, sub-acute appendicitis, 
fundoplication, incisional hernia repair and inguinal hernia repair. They 
were randomized into 2 groups (n=50 each). They underwent 
laparoscopic surgeries during this study period. Group-A receives port 
site infiltration of bupivacaine and group-B receives conventional 
analgesia (tramadol). 
 There is no significant difference between the groups in terms of 
age, sex and weight of the patient. duration of surgery in group 
A(65.3±19.41) and group B(65.5±20.53) which is not statistically 
significant (p-0.960) .number of patients having moderate to severe pain 
was higher in group B after surgery compared to those in group A. lower 
visual analogue scores were observed in group A compared to group B at 
1,4,8 and 12 hrs which is significant with p -value – 0.001.rescue 
analgesic consumption in the first 12 hrs after surgery was also 
significantly less in group A(87% required no dose,19% demanding 
once,22% twice) compared to group B (13%required no 
dose,81%demanding once,78%twice) with p-value-0.001. The side 
  
effects were also significantly less in group A compared to group B(P-
0.037). 
RESULTS 
TABLE-1 : MEAN DISTRIBUTION OF AGE  
 
AGE (IN YEARS) 
GROUP MEAN SD 
A 31.22 11.3 
B 30.82 10.34 
P-VALUE - 0.854 
 
 
 
 
17
38
24
17
4
GRAPH-1 AGE DISTRIBUTION
<20 21-30 31-40 41-50 > 50
  
 
 
 
 
       
    The mean age in group A was 31.22±11.3 and in group B it was 
30.82±10.34 years which was comparable in both groups (p=0.854 
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                                       TABLE-2 SEX DISTRIBUTION 
SEX NO OF PATIENTS PERCENTAGE 
MALE 47 47% 
FEMALE 53 53% 
 
 
GRAPH-2 SEX DISTRIBUTION
 
    Of the 100 patients in the  study population, males were 47% and 
females were 53%. 
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TABLE-3 : MEAN DISTRIBUTION OF WEIGHT OF THE 
PATIENTS IN KG 
 
WEIGHT IN KG 
GROUP MEAN SD 
A 53.08 8.75 
B 52.82 8.01 
P VALUE - 0.880 
 
 
 Mean weight of the patient in group A was 53.08±8.75 and that 
of group B was 52.82±8.0 kgs which were comparable in both the groups 
(p=0.880). 
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TABLE-4 : MEAN DISTRIBUTION OF DURATION OF 
SURGERY IN MINUTES 
 
DURATION OF SURGERY (IN MIN) 
GROUP MEAN SD 
A 65.3 19.41 
B 65.5 20.53 
P -VALUE - 0.960 
 
 
 The graph-4 shows mean operative time in group-A was (65.3 
±19.41mins) and that of group-B was (65.5±20.53 mins) and were not 
found to be statistically significant (p- value - >0.05). 
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STATISTICS OF SURGERIES PERFORMED: 
PROCEDURE NO OF PATIENTS PERCENTAGE 
LAP APPENDICECTOMY 59 59% 
LAP CHOLECYSTECTOMY 24 24% 
DIAGNOSTIC LAPROSCOPY 2 2% 
LAP FUNDOPLICATION 2 2% 
LAP HERNIA REPAIR 12 12% 
LAP & PROCEED 1 1% 
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VAS scale was used to assess the intensity of pain at 1
st
,4
th
 ,8
th
, and 
12
th
 hours after surgery.  
TABLE-5: MEAN DISTRIBUTION AND P VALUE OF VISUAL 
ANALOGUE SCALE @ 1 HOUR 
 
VISUAL ANALOGUE SCALE @ 1 HR 
GROUP MEAN SD 
A 0.6 0.85 
B 1.36 0.98 
P -VALUE - 0.001 
SIGNIFICANT 
UNPAIRED T -TEST 
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The mean visual analogue score at 1
st
 hour for group-A was 0.6 +  
0.85 and for group-B was 1.36 +  0.98 and the p-value is 0.001 which was 
statistically significant. 
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TABLE-6: MEAN DISTRIBUTION AND P-VALUE OF VISUAL 
ANALOGUE SCALE @ 4 HOUR  
 
GROUP 
VISUAL ANALOGUE SCALE -4 HR A B 
ZERO 25 10 
ONE 15 20 
TWO 8 21 
THREE 2 9 
P- VALUE - 0.001 
SIGNIFICANT 
KRUSKAL WALLIS TEST 
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VISUAL ANALOGUE SCALE @ 4 HR 
GROUP MEAN SD 
A 0.74 0.87 
B 1.78 0.73 
P -VALUE - 0.001 
SIGNIFICANT 
UNPAIRED T- TEST 
 
 
The mean visual analogue score at 4
th
 hour for group-A was 0.74 
and for group-B was 1.78 and the P- value is 0.001 which was 
statistically significant. 
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TABLE -7 : MEAN DISTRIBUTION AND P VALUE OF VISUAL 
ANALOGUE SCALE@ 8 HOUR 
 
                              GROUP 
VISUAL ANALOGUE SCALE -8 HR A B 
ZERO 23 5 
ONE 25 20 
TWO 2 15 
THREE 0 4 
P -VALUE - 0.001 
SIGNIFICANT 
KRUSKAL WALLIS TEST 
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VISUAL ANALOGUE SCALE @ 8 HR 
GROUP MEAN SD 
A 0.58 0.52 
B 1.36 0.77 
P -VALUE - 0.001 
SIGNIFICANT 
UNPAIRED T -TEST 
 
 
The mean visual analogue score at 8
th
 hour for group-A was 0.58 
and for group-B was 1.36 and the p- value is 0.001 which was statistically 
significant. 
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TABLE-8: MEAN DISTRIBUTION AND P VALUE OF VISUAL 
ANALOGUE SCALE @ 12 HOUR 
 
GROUP 
VISUAL ANALOGUE SCALE -12 HR A B 
ZERO 5 13 
ONE 45 17 
TWO 0 12 
THREE 0 8 
P- VALUE - 0.001 
SIGNIFICANT 
KRUSKAL WALLIS TEST 
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VISUAL ANALOGUE SCALE @ 12 HR 
GROUP MEAN SD 
A 0.9 0.3 
B 1.3 1.03 
P -VALUE - 0.001 
SIGNIFICANT 
UNPAIRED T- TEST 
 
 
The mean visual analogue score at 12
th
 hour for group-A was 0.9 
and for group-B was 1.3 and the p- value is 0.001 which was statistically 
significant. 
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TABLE-9: TABLE SHOWING P VALUE FOR RESCUE 
ANALGESIC REQUIREMENT 
 
GROUP 
RESCUE ANALGESICS NEEDED A B 
NIL 40 6 
ONE 8 35 
TWO 2 9 
P -VALUE - 0.001 
SIGNIFICANT 
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GRAPH-9: RESCUE ANALGESIC 
REQUIREMENT
BUPIVACAINE TRAMADOL
  
 
GROUP 
RESCUE ANALGESICS NEEDED A B 
YES 10 44 
NO 40 6 
 
 
Rescue analgesic consumption in the 1
st
 12 hours after surgery was 
also significantly less in group-A (19% demanding once, 22% twice and 
87% requiring no dose) Whereas group-B (81% need for single dose, 78 
% two doses) 
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46
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Number of patients requiring rescue analgesics in group A was 10 (n-
50)compared to group B which was 44 (n-50) 
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TABLE-10: TABLE SHOWING P VALUE OF SIDE EFFECTS 
(NAUSEA/VOMITING) 
 
GROUP 
SIDE EFFECTS A B 
PRESENT 3 10 
ABSENT 47 40 
P -VALUE - 0.037 
SIGNIFICANT 
 
 
 
 
 
 
 
The side effects such as nausea and vomiting due to opioids, were 
also less in group-A than in tramadol group and that difference is 
statistically significant (p=0.037). 
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DISCUSSION: 
 Although Laparoscopic surgeries compared with open surgery, 
associated with reduced surgical trauma and pain, still early postoperative 
pain
5,9
 after a laparoscopic procedure is a common complaint. 
Laparoscopic procedures are nowadays practiced as a daycare 
procedures, thus providing adequate post-operative pain relief is 
important so that patients can be discharged on the same day. Pain after 
laparoscopic surgery arises from three main source-50-70% arising from 
incision site (somatic pain), 20-30% by pneumoperitoneum (referred 
pain) and 10-20 % by surgical site (visceral pain). 
 Therefore multimodal analgesia is most probably the best way to 
reduce the postoperative pain. There is a long history of  NSAID’s and 
Narcotics being used in the postoperative pain relief. But Narcotics have 
its own side effects like confusion, respiratory depression, vomiting. 
 NSAID’s can cause both analgesic effects and unwanted side 
effects. However, it does have the additional benefit that it does not cause 
nausea and vomiting associated with opioids
15
. 
 Therefore if any modality that has the capability of pain control
4 
with no severe side effects will be more practical and safer than 
conventional methods. 
  
 The current study demonstrates infiltration of local anesthetic 
agents at the port site after laparoscopic surgery.A study by Cantore et al 
said that somatic pain is more important than visceral pain during early 
postoperative period. This current study mainly focused on incision site 
pain(somatic pain) and benefits of local anaesthetics. 
 Local anesthetic agents if used with a proper method can have 
many benefits 
 Reduce the need for narcotics and NSAID’s and hence the side 
effects too. 
 They don’t have a sedative effect and hence patient can be 
ambulated earlier. 
 The intensity of pain relief was good. 
 Patient can be discharged early and reduce the hospital stay and 
hence cost effective 
The current study showed that infiltration of  bupivacaine into the port 
sites reduces the intensity of pain during the early postoperative period 
compared to conventional analgesics. It also reduces the requirement of 
narcotics during the postoperative period and hence adverse effects. 
There was no adverse effects such as cardiovascular alterations, 
circumoral numbness, nystagmus, muscle fasciculations noted in any of 
the patients received bupivacaine in this study. 
  
          The study compares two groups. Group A receives port site 
infiltration of bupivacaine and group B receives tramadol intravenous 
immediately after surgery.visual analogue scale was used to assess the 
intensity of pain at 1,4.8 and 12 hrs after surgery. A number of patients 
having moderate to severe pain in early postoperative period was higher 
in group B compared to bupivacaine group. A number of patients having 
no pain was less in group B but most of the patients were painless in the 
early 12 hrs after surgery in group A.  
The rescue analgesic (ketorolac intravenous) requirement was also 
higher in group B which was significantly different from bupivacaine 
group and hence side effects also less in bupivacaine group.   
Similarly, in a study in Italy,Cantore and et al documented pre-
incision local infiltration with levobupivacaine reduces the pain in early 
post -op period and also reduces the rescue analgesic consumption after 
laparoscopic cholecystectomy.  Johnson et al have conducted two 
consecutive studies with intra-peritoneal bupivacaine and peri-portal 
injection of bupivacaine after surgery. Their results showed that 
intraperitoneal instillation of bupivacaine has similar efficacy as port site 
infiltration. 
 
  
CONCLUSION 
   Infiltration of local anaesthetic agents through laparoscopic port 
sites at the end of laparoscopic surgeries not only can control the intensity 
of pain effectively in the early postoperative period but also can decrease 
the need for narcotics and NSAIDs. They are recommended in the post-
operative period for all laparoscopic surgeries without any limitations. 
Patients feel better because of decreased narcotics side effects. This study 
concludes infiltration of bupivacaine through laparoscopic port sites at 
the end of the surgery during port withdrawal, can achieve effective 
results.  
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ANNEXURE I- CONSENT FORM 
YOUR PARTICIPATION 
       You Mr/Ms/Mrs____________`________ age _____ sex______ 
Ip.no_______ are being asked to be a participant in the research study 
titled “COMPARATIVE STUDY OF PORT SITE INFILTRATION OF 
BUPIVACAINE VS CONVENTIONAL ANALGESICS IN 
CONTROLLING POST OPERATIVE PAIN FOLLOWING 
LAPAROSCOPIC SURGERIES”  
          A one year randomized controlled study conducted by 
Dr.__________, postgraduate student , department of general surgery, 
Coimbatore medical college. You are eligible after looking into inclusion 
criteria. Before you agree to participate in this study you can read this 
form and ask any questions. 
 
PURPOSE OF RESEARCH 
            To study the postoperative analgesic effect of Bupivacaine 
following port site infiltration and conventional analgesia after 
laparoscopic surgeries. 
 
METHODOLOGY 
           You will be randomly allocated in to group A and group B. If you 
are in group A you will receive 20ml of 0.25% Bupivacaine at the port 
  
site after removal of  trocar and if you are in group B you will receive 
100mg of Tramadol intravenous. Postoperative pain will be assessed 
using visual analogue scale at 1,4,8 and 12 hours. 
 
POTENTIAL RISK 
No serious side effects  
 
BENEFITS OF TAKING PART IN THIS RESEARCH 
Prevention of postoperative pain. 
Lesser requirement of opioids and NSAIDS in postoperative period. 
 
OTHER OPTIONS 
 You may have the option to decline from participation in the study 
without any discrimination. 
 The new information collected during the study will be told as and 
when required. 
 Privacy of the individual will be respected and kept confidential. 
 Participation in this study is free of cost. 
 Researcher can remove you from the study if circumstances arises. 
 
 
 
  
WHOM TO CONTACT 
              For any information about the study, during or after the study 
may be collected from  
Dean, Coimbatore medical college , Coimbatore 
Dr.__________ professor,Department of general surgery, Coimbatore 
medical college 
Dr.__________ postgraduate student , Department of general surgery, 
Coimbatore medical college, Coimbatore. 
 
 
 
Participant’s name:                                                Witness name: 
Signature:                                                               Signature 
Date:                                                                       Date: 
Place:                                                                     Place: 
 
  
   
 
 
 
  
ANNEXURE II 
 PROFORMA FOR POSTOPERATIVE PAIN EVALUATION 
NAME :       AGE  
 : 
ADDRESS :       WEIGHT 
 : 
I.P. NO :       OCCUPATION
 : 
DOA :       DOS  
 :  
H/O SMOKING/ALCOHOL INTAKE  :     
H/O ANY PSYCHIATRIC ILLNESS                      : 
CHRONIC AILMENT    : 
H/O PREVIOUS DRUG INTAKE   : 
COMORBID CONDITIONS    : 
ASA      : I/II/III/IV 
ANAESTHESIA TYPE    : GA/EPIDURAL 
DURATION OF ANAESTHESIA   : 
DRUGS USED DURING ANASTHESIA  : 
LAPAROSCOPIC PROCEDURE   : 
NO. OF PORTS      : 
GAS USED FOR PNEUMOPERITONEUM : 
INTRA ABDOMINAL PRESSURE   : 
DURATION OF SURGERY    : 
POST OP ANALGESIA USED                         : BUPIVACAINE/TRAMADOL  IV 
 
 
  
PAIN SCORE 
NAME:   AGE:   SEX:   IP NO: 
Visual Analogue scale on 1, 4, 8 and 12 hours. 
 
VAS 
1 HR 4 HR 8 HR 12 HR 
BP- 
PR- 
BP- 
PR- 
BP- 
PR- 
BP- 
PR- 
INTENSE 
PAIN 
10     
9     
8     
MODERATE 
PAIN 
7     
6     
5     
4     
MILD PAIN 
3     
2     
1     
NO PAIN 0     
 
 
 
 
 
 
 
  
RESCUE ANALGESIC REQUIREMENT AND SIDE 
EFFECTS 
 
NAME:   AGE:   SEX:   IP NO: 
 
 
RESCUE ANALGESIC 
CONSUMPTION 
YES 
NO 
ONCE TWICE 
NAUSEA/VOMITING   
POST-OP WOUND 
COMPLICATION 
  
 
 
 
 
 
 
 
 
 
  
GROUP-A
NO 
PAIN-
0
MILD-
1
MOD
ERAT
E-2
SEVE
RE-3
S.No Name
Age/
Sex
Weigh
t of 
patien
t (kg)
Dura
tion 
of 
Surg
ery 
(min
s)
Diagnosis Procedure 1hr 4hr 8hr 12hr
NOT 
REQUIRED-
0, ONCE-1, 
TWO-2
NIL-0, 
NAUSEA/VOMI
TING-1, POST-
OP WOUND 
COMPLICATION-
2
1 prema latha 33/F 52 50 Sub-acute Appendicitis Lap.Appendicectomy 0 1 1 0 0 0
2 kavitha 23/F 51 50 Sub-acute Appendicitis Lap.Appendicectomy 0 0 1 1 0 0
3 Rasathi 41/F 56 90 Calculous Cholecystitis Lap.cholecystectomy 0 0 1 1 0 0
4 kanmani 27/F 48 40 Sub-acute Appendicitis Lap.Appendicectomy 0 0 0 1 0 0
5 pushpa 31/F 62 60 Sub-acute Appendicitis Lap.Appendicectomy 1 2 1 1 1 0
6 maragatham 55/F 68 80 Calculous Cholecystitis Lap.cholecystectomy 0 0 0 1 0 0
7 revathi 22/F 45 65 Sub-acute Appendicitis Lap.Appendicectomy 0 1 1 1 0 0
8 shanthi 32/F 58 45 Sub-acute Appendicitis Lap.Appendicectomy 0 0 0 1 0 0
9 sheela 33/F 51 55 Sub-acute Appendicitis Lap.Appendicectomy 0 0 1 1 0 0
10 jothi 19/F 50 60 Sub-acute Appendicitis Lap.Appendicectomy 2 3 2 1 2 1
11 rani 21/F 40 65 Sub-acute Appendicitis Lap.Appendicectomy 1 1 0 1 0 0
12 muthumani 50/F 75 75 Incisional hernia Lap.Hernia repair 0 0 1 1 0 0
13 sarashwathi 34/F 59 70 Calculous Cholecystitis Lap.cholecystectomy 0 2 1 1 1 0
14 rena 28/F 50 100 Ileocaecal intussusception Laparoscopy and proceed 0 0 1 1 0 0
15 kanamma 26/F 44 55 Sub-acute Appendicitis Lap.Appendicectomy 3 1 0 1 1 0
16 sudhakar 23/M 51 45 Sub-acute Appendicitis Lap.Appendicectomy 1 1 0 1 0 0
17 raja 15/M 48 55 Sub-acute Appendicitis Lap.Appendicectomy 0 0 1 1 0 0
18 gopal 51/M 54 90 Calculous Cholecystitis Lap.cholecystectomy 2 2 1 1 1 0
19 vijayan 25/M 50 65 Sub-acute Appendicitis Lap.Appendicectomy 0 0 1 1 0 0
20 kuppusamy 54/M 56 90 Recurrent inguignal hernia Laparoscopic repair 0 1 0 1 0 0
VAS RESCUE 
ANALGESI
A 
REQUIREM
ENT
SIDE EFFECTS 
  
21 govindaraj 32/M 58 75 Calculous Cholecystitis Lap.Cholecystectomy 0 0 0 1 0 0
22 kumar 24/M 50 55 Sub-acute Appendicitis Lap.Appendicectomy 0 0 0 1 0 0
23 joseph 33/M 56 40 Right varicocele Diagnostic laparoscopy 1 2 1 0 1 1
24 ravishankar 45/M 61 50 Congenital hernia Laparoscopic repair 0 0 0 1 0 0
25 mohanraja 26/M 56 45 Sub-acute Appendicitis Lap.Appendicectomy 1 1 0 1 0 0
26 senthil 31/M 62 85 Calculous Cholecystitis Lap.Cholecystectomy 0 0 1 1 0 0
27 kalimuthu 43/M 60 70 Recurrent inguignal hernia Lap.Hernia repair 2 2 1 0 1 0
28 muthusamy 57/M 60 120 Hiatus hernia Lap.fundoplication 1 1 0 1 0 0
29 nagalingam 15/M 40 40 Sub-acute Appendicitis Lap.Appendicectomy 0 0 0 1 0 0
30 Arifa 23/F 42 50 Sub-acute Appendicitis Lap.Appendicectomy 0 1 1 1 0 0
31 mumtaz 40/F 63 95 Calculous Cholecystitis Lap.cholecystectomy 0 0 1 1 0 0
32 rajeshwari 25/F 43 60 Sub-acute Appendicitis Lap.Appendicectomy 0 0 1 1 0 0
33 mariyammal 40/F 68 100 Incisional hernia Lap.Hernia repair 0 0 1 1 0 0
34 priya 22/F 38 70 Sub-acute Appendicitis Lap.Appendicectomy 1 1 0 1 0 0
35 kalaivani 13/F 34 65 Sub-acute Appendicitis Lap.Appendicectomy 2 2 1 1 1 1
36 devi 38/F 68 60 Calculous Cholecystitis Lap.cholecystectomy 1 1 0 1 0 0
37 beena 26/F 48 35 Sub-acute Appendicitis Lap.Appendicectomy 0 0 0 1 0 0
38 kalpana 13/F 38 45 Sub-acute Appendicitis Lap.Appendicectomy 2 2 1 1 0 0
39 yogaraj 25/M 50 50 Sub-acute Appendicitis Lap.Appendicectomy 0 0 0 1 0 0
40 prasanth 18/M 46 55 Sub-acute Appendicitis Lap.Appendicectomy 1 1 1 1 0 0
41 raman 28/M 52 60 Sub-acute Appendicitis Lap.Appendicectomy 0 0 0 1 0 0
42 thangamani 45/M 58 65 Calculous Cholecystitis Lap.cholecystectomy 3 3 2 1 2 0
43 subramaniyam 42/M 60 90 Recurrent inguignal hernia Lap.Hernia repair 1 1 0 0 0 0
44 panner 33/M 60 70 Calculous Cholecystitis Lap.cholecystectomy 0 0 1 1 0 0
45 gokul 29/M 45 65 Sub-acute Appendicitis Lap.Appendicectomy 0 0 0 1 0 0
46 vellingiri 25/M 48 50 Sub-acute Appendicitis Lap.Appendicectomy 1 1 0 1 0 0
47 ponraj 32/M 59 75 Calculous Cholecystitis Lap.Cholecystectomy 2 2 1 1 1 0
48 sadhasivam 50/M 60 110 Recurrent inguignal hernia Lap.Hernia repair 0 0 0 1 0 0
49 mishudevanth 19/M 45 55 Sub-acute Appendicitis Lap.Appendicectomy 0 0 1 0 0 0
50 ramanan 36/M 58 55 Calculous Cholecystitis Lap.Cholecystectomy 1 1 0 1 0 0
 
  
GROUP-B
NO 
PAIN-
0
MILD-
1
MODE
RATE-
2
SEVERE-
3
S.N
o
Name
Age/S
ex
Weight 
of 
patient 
(kg)
Durati
on of 
Surger
y 
(mins)
Diagnosis Procedure 1hr 4hr 8hr 12hr
NOT 
REQUIRED-
0, ONCE-1, 
TWO-2
NIL-0, 
NAUSEA/VO
MITING-1, 
POST-OP 
WOUND 
COMPLICATI
ON-2
1 lakshmi 20/F 45 60 Sub Acute Appendicitis Lap.Appendicectomy 3 3 1 0 1 1
2 sarojini 48/F 62 70 Calculous Cholecystitis Lap.Cholecystectomy 2 2 1 2 1 0
3 marimuthammal 50/F 68 100 Incisional hernia Lap.Hernia repair 2 2 1 1 1 0
4 ambika 40/F 65 75 Calculous Cholecystitis Lap.Cholecystectomy 1 3 1 1 1 0
5 kalaipriya 33/F 52 65 Sub Acute Appendicitis Lap.Appendicectomy 1 1 2 1 1 1
6 divya 38/F 50 50 Sub Acute Appendicitis Lap.Appendicectomy 2 1 2 1 1 0
7 shanthi 45/F 60 90 G.B.Polyp Lap.Cholecystectomy 1 1 0 1 0 0
8 viji 20/F 45 55 Sub Acute Appendicitis Lap.Appendicectomy 3 2 1 2 1 0
9 selvi 30/F 48 50 Sub Acute Appendicitis Lap.Appendicectomy 0 1 2 0 0 0
10 baby rani 42/F 68 80 Calculous Cholecystitis Lap.Cholecystectomy 1 1 2 1 1 0
11 chandra 19/F 40 45 Sub Acute Appendicitis Lap.Appendicectomy 1 2 3 1 1 0
12 mohanapriya 25/F 42 50 Sub Acute Appendicitis Lap.Appendicectomy 3 2 2 3 2 1
13 Ranjani 22/F 44 55 Sub Acute Appendicitis Lap.Appendicectomy 0 1 1 0 0 0
14 priyaamudha 38/F 68 90 Calculous Cholecystitis Lap.Cholecystectomy 1 2 1 2 1 0
15 kaladevi 29/F 45 60 Sub Acute Appendicitis Lap.Appendicectomy 2 2 1 3 1 0
16 shankar 23/M 50 65 Sub Acute Appendicitis Lap.Appendicectomy 3 2 1 0 1 1
17 sudhakar 42/M 56 95 Calculous Cholecystitis Lap.Cholecystectomy 1 2 2 1 1 1
18 suresh 29/M 54 70 Sub Acute Appendicitis Lap.Appendicectomy 1 1 2 0 1 0
19 balu 22/M 50 50 Sub Acute Appendicitis Lap.Appendicectomy 0 1 0 2 1 0
20 vasanth 30/M 56 60 Calculous Cholecystitis Lap.Cholecystectomy 1 3 1 2 2 0
21 palani 50/M 48 90 Bubonocele Lap.Hernia repair 1 1 1 0 1 0
22 mayilsamy 33/M 56 40 RIF Mass Diagnostic laparoscopy 1 2 2 1 1 0
VAS
RESCUE 
ANALGESIA 
REQUIREM
ENT
SIDE 
EFFECTS
 
  
23 renuka devi 14/F 45 60 Sub Acute Appendicitis Lap.Appendicectomy 0 2 2 3 1 0
24 alagammal 44/F 62 130 Hiatus hernia Lap.Fundoplication 2 3 3 1 2 1
25 arusamy 36/M 58 65 Calculous Cholecystitis Lap.Cholecystectomy 1 3 2 2 2 0
26 john 40/M 55 100 Inguignal Hernia Lap.Hernia repair 2 3 2 3 2 1
27 gopalan 38/M 60 75 Calculous Cholecystitis Lap.Cholecystectomy 2 2 1 1 1 0
28 krishnan 20/M 38 40 Sub Acute Appendicitis Lap.Appendicectomy 1 1 3 2 1 0
29 kumar 19/M 40 60 Sub Acute Appendicitis Lap.Appendicectomy 2 2 1 1 1 0
30 Arun 26/M 46 65 Sub Acute Appendicitis Lap.Appendicectomy 0 1 0 0 0 0
31 Gokila 22/F 44 70 Sub Acute Appendicitis Lap.Appendicectomy 1 3 2 2 1 1
32 Rathika 28/F 48 60 Sub Acute Appendicitis Lap.Appendicectomy 1 2 1 0 1 0
33 Bakiyalakshmi 36/F 65 95 Calculous Cholecystitis Lap.Cholecystectomy 1 1 2 2 1 0
34 saraswathi 19/F 48 45 Sub Acute Appendicitis Lap.Appendicectomy 3 3 1 3 2 1
35 vijaya 27/F 56 40 Sub Acute Appendicitis Lap.Appendicectomy 2 2 2 3 2 0
36 sangeetha 30/F 58 50 Sub Acute Appendicitis Lap.Appendicectomy 3 1 1 1 1 0
37 valliyammal 35/F 60 60 Calculous Cholecystitis Lap.Cholecystectomy 0 1 0 1 0 0
38 Rajammal 45/F 65 55 Calculous Cholecystitis Lap.Cholecystectomy 1 2 1 0 1 0
39 vanitha 20/F 40 55 Sub Acute Appendicitis Lap.Appendicectomy 1 2 1 1 1 0
40 Rani 25/F 45 45 Sub Acute Appendicitis Lap.Appendicectomy 3 1 1 0 1 0
41 Rajammal 50/F 68 100 Incisional hernia Lap.Hernia repair 2 1 2 3 2 1
42 Bakiyam 26/F 52 60 Sub Acute Appendicitis Lap.Appendicectomy 2 2 1 2 1 0
43 Sakthivel 25/M 52 40 Sub Acute Appendicitis Lap.Appendicectomy 0 1 0 1 1 0
44 Aarusamy 32/M 52 55 Sub Acute Appendicitis Lap.Appendicectomy 1 2 3 2 1 0
45 Raja 15/M 45 60 Sub Acute Appendicitis Lap.Appendicectomy 1 2 1 0 1 0
46 prakash 29/M 54 65 Sub Acute Appendicitis Lap.Appendicectomy 3 3 1 3 2 0
47 Durairaj 50/M 60 110 Incisional hernia Lap.Hernia repair 0 1 1 1 1 0
48 Senthil kumar 24/M 52 40 Sub Acute Appendicitis Lap.Appendicectomy 2 2 1 0 1 0
49 Hariharan 22/M 53 45 Sub Acute Appendicitis Lap.Appendicectomy 0 1 1 2 1 0
50 chandran 16/M 48 65 Sub Acute Appendicitis Lap.Appendicectomy 0 1 1 0 0 0
 
